Detalles de la búsqueda
1.
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.
Pharmacoepidemiol Drug Saf
; 30(3): 350-359, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197106
2.
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
Pharmacoepidemiol Drug Saf
; 30(3): 334-341, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099846
3.
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance.
Pharmacoepidemiol Drug Saf
; 25(6): 705-12, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27004571
Resultados
1 -
3
de 3
1
Próxima >
>>